Pharma Stocks
Latest news, explainers and analysis on Pharma Stocks. Tracking 10 stories on Arth Vani.
Connected in the graph
Latest on Pharma Stocks
Dr Reddy's Shares Drop 7% as Quality Issues Delay Weight-Loss Drug Launch
Shares of Dr Reddy’s Laboratories witnessed a sharp decline after the company paused commercial supplies of its semaglutide product. The delay stems from quality concerns regarding the active pharmaceutical ingredient (API) used in the drug.
Pfizer Faces Dual Crisis: Stock Performance Slumps as Iconic Headquarters Decays
Pharmaceutical giant Pfizer is grappling with a significant decline in stock value alongside the physical deterioration of its former landmark building. This trend highlights the company's struggle to maintain its pandemic-era momentum in a post-COVID market.
Divi's Laboratories Stock Sees Volatility Amidst Market Activity
Divi's Laboratories experienced fluctuations in its share price today, reflecting ongoing market activity. Investors are closely monitoring the company's performance and sector trends.
HDFC Mutual Fund and ADIA Invest ₹777 Crore in Pharma Firm Corona Remedies
Major institutional investors, led by HDFC Mutual Fund and the Abu Dhabi Investment Authority (ADIA), have acquired stakes in Corona Remedies via a massive block deal. The shares were offloaded by existing investors Sepia Investments and Anchor Partners for approximately ₹777 crore.
Zydus Lifesciences Expands US Footprint with ₹1,400 Crore Assertio Acquisition
Indian pharmaceutical major Zydus Lifesciences has completed the acquisition of US-based Assertio Holdings for approximately ₹1,400 crore ($166.4 million). The move aims to strengthen Zydus's portfolio in high-value specialty drugs and cancer support therapies.
Shift to Safety: Why Top Fund Managers are Betting on Pharma Amid Global Tensions
As West Asian conflicts and US inflation create a volatile environment for Indian stocks, experts are moving toward defensive sectors. Investors are advised to be cautious with IT and Metals while looking at Healthcare for stability.
Cipla Stock Watch: How This Pharma Major Performed for Retail Investors Recently
Cipla, a heavyweight in the Nifty 50, remains under the spotlight as retail investors track its short-term price momentum. This performance analysis breaks down the stock's recent returns and what they mean for your pharmaceutical portfolio.
Pharma Stocks Shine: Why Indian Drugmakers Are Beating Market Volatility
Indian pharmaceutical stocks have emerged as a safe haven for investors, delivering strong returns despite global economic pressures. This growth is fueled by rising domestic medicine demand and a global shift in supply chains away from China.
Dr Reddy’s Shares Slip Below Key Levels; Analysts Signal Bearish Trend
Shares of pharmaceutical giant Dr Reddy's Laboratories have fallen below their 100-day moving average, a key technical indicator used by traders to gauge long-term momentum. This breach suggests a potential downward trend for the Nifty 50 constituent, which is a staple in many Indian retail and mutual fund portfolios.
Concord Biotech Shares Jump 6% Following USFDA Approval for Arthritis Tablets
Shares of Concord Biotech rose sharply after the company received a green light from the US health regulator for its Tofacitinib tablets. This approval allows the firm to enter a lucrative $500 million US market for rheumatoid arthritis treatments.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.